<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02265562</url>
  </required_header>
  <id_info>
    <org_study_id>10102014</org_study_id>
    <nct_id>NCT02265562</nct_id>
  </id_info>
  <brief_title>Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy</brief_title>
  <official_title>Evaluation of the Effect of Rectal Misoprostol on Blood Loss During Abdominal Hysterectomy: A Double Blind Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hysterectomy, as any major operation, can cause complications, as hemorrhage which may occur
      in some cases and sometimes requiring blood transfusion. Recent study proved that misoprostol
      success in reducing blood loss during total abdominal hysterectomy when used once before the
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we tried to assess the efficacy of misoprostol in minimize blood loss during
      hysterectomy when used as single preoperative dose via rectal route. The reduction of blood
      flow may be due to the combined effect of myometrial contraction and vasoconstrictive effect
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>8 months</time_frame>
    <description>amount of intra-operative blood loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative hemoglobin level</measure>
    <time_frame>8 months</time_frame>
    <description>level of serum hemoglobin postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Blood Loss</condition>
  <arm_group>
    <arm_group_label>Misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60 minutes before the surgery 400 μg of misoprostol (2 tablets of 200 μg) inserted rectally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>60 minutes before the surgery 2 tablets of placebo tablets inserted rectally</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>60 minutes before the surgery 400 μg of misoprostol (2 tablets of 200 μg) inserted rectally</description>
    <arm_group_label>Misoprostol</arm_group_label>
    <other_name>prostaglandin E1 analogue</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>60 minutes before the surgery 2 tablet of placebo inserted rectally</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Dizirest B6</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A- Age: adult female &gt;18 years old. B- Any women undergoing abdominal hysterectomy. C- No
        contraindications to misoprostol.

        Exclusion Criteria:

        A -Women with any contraindications to misoprostol including heart disease, mitral stenosis
        , severe hypertension ( diastolic pressure over100mm Hg) , hematologic disorders (as sickle
        cell anemia ), glaucoma, bronchial asthma, liver disease.

        B- Known history of or active medical disorder as DM . C- Pelvic endometriosis and adnexal
        mass. D- Those who had undergone previous myomectomy. E- Women who received GnRH analogues
        and mifepristone and who are allergic to prostaglandins.

        F- Women with mental impairment or incompetent in giving consent. G- Women who don't wish
        to participate in the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waleed El-khyatat, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Waleed EL-khayat, M.D.</last_name>
    <phone>01005135542</phone>
    <phone_ext>+2</phone_ext>
    <email>waleed_elkhyat@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo University hospiatl</name>
      <address>
        <city>Cairo</city>
        <zip>12311</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Waleed El-khayat, M.D.</last_name>
      <phone>01005135542</phone>
      <phone_ext>002</phone_ext>
      <email>waleed_elkhyat@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2014</study_first_submitted>
  <study_first_submitted_qc>October 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2014</study_first_posted>
  <last_update_submitted>October 15, 2014</last_update_submitted>
  <last_update_submitted_qc>October 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Waleed El-khayat</investigator_full_name>
    <investigator_title>Assistant Professor of Obstetrics &amp; Gynecology</investigator_title>
  </responsible_party>
  <keyword>Hysterectomy</keyword>
  <keyword>Misoprostol</keyword>
  <keyword>Blood loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

